107 related articles for article (PubMed ID: 455871)
1. A re-evaluation of intersubject variation in enzyme induction in man.
Branch RA; Shand DG
Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
[TBL] [Abstract][Full Text] [Related]
2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
3. Enzyme induction and beta-adrenergic receptor blocking drugs.
Branch RA; Herman RJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
[TBL] [Abstract][Full Text] [Related]
4. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
Tse FL; Chang T; Jaffe JM
Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
[TBL] [Abstract][Full Text] [Related]
5. Enzyme induction and renal function in man.
Ohnhaus EE; Martin J; Kinser J; Colombo JP
Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
[TBL] [Abstract][Full Text] [Related]
6. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
Sotaniemi EA
Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
[No Abstract] [Full Text] [Related]
7. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
Maddocks JL; Wake CJ; Harber MJ
Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
[TBL] [Abstract][Full Text] [Related]
8. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.
Homeida M; Roberts CJ; Halliwell M; Read AE; Branch RA
Gut; 1979 Jul; 20(7):596-601. PubMed ID: 488757
[TBL] [Abstract][Full Text] [Related]
9. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
Espiritu-Quiza MF; Skinner MH; Blaschke TF
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
Pei YY; Bialer M; Levy RH
Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
[TBL] [Abstract][Full Text] [Related]
12. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
Roberts CJ; Jackson L; Halliwell M; Branch RA
Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
[TBL] [Abstract][Full Text] [Related]
13. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
14. Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.
Salem SA; King DJ; McDevitt DG
Psychopharmacology (Berl); 1982; 78(2):147-9. PubMed ID: 6817372
[TBL] [Abstract][Full Text] [Related]
15. The features of hepatic enzyme induction with glutethimide in man.
Jackson L; Homeida M; Roberts CJ
Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
17. Antipyrine disposition and liver size in the elderly.
Swift CG; Homeida M; Halliwell M; Roberts CJ
Eur J Clin Pharmacol; 1978 Nov; 14(2):149-52. PubMed ID: 720377
[TBL] [Abstract][Full Text] [Related]
18. Effect of pesticide exposure on human microsomal enzyme induction.
Uppal R; Sharma PR; Chaudhury RR
Hum Toxicol; 1982 Mar; 1(2):155-8. PubMed ID: 7173896
[TBL] [Abstract][Full Text] [Related]
19. Bioimpedance assessment of antipyrine pharmacokinetics before and after enzyme induction.
Pilla AM; Zarowitz BJ; Svensson CK; Peterson EL; Popovich J
DICP; 1990 Jun; 24(6):575-80. PubMed ID: 2360333
[TBL] [Abstract][Full Text] [Related]
20. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
Bakke OM; Bending M; Aarbakke J; Davies DS
Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
